SGRY as reported
Surgery Partners, Inc. reported $3.37B of revenue over the trailing twelve months, +4.0% on the year before. 11 reported series are charted on this page, each one as filed.
$3.37B
Revenue, trailing twelve months · to Q2 2026 · +4.0% against the twelve months before
- Net Income
- −$89M
Net Income · −51% year on year · trailing twelve months to Q2 2026
- Free Cash Flow
- $188M
Free Cash Flow · +7.0% year on year · trailing twelve months to Q2 2026
- Op Margin
- 11%
Op Margin · trailing twelve months to Q2 2026
| Series | Latest | Year on year | As of |
|---|---|---|---|
| Revenue | $3.37B | +4.0% | Q2 2026 |
| Net Income | −$89M | −51% | Q2 2026 |
| EPS | −$0.69 | −52% | Q2 2026 |
| Gross Margin | 23% | n/a | Q4 2019 · 26 quarters behind |
| Op Margin | 11% | n/a | Q2 2026 |
| Net Margin | −2.7% | n/a | Q2 2026 |
| ROE | −6.1% | n/a | Q2 2026 |
| ROA | −1.3% | n/a | Q2 2026 |
| ROIC | 6.0% | n/a | Q2 2026 |
| Free Cash Flow | $188M | +7.0% | Q2 2026 |
| P/E | 103 | n/a | Q2 2017 · 36 quarters behind |
Every figure straight from the statements as filed with the SEC, no scoring, no adjustment. Open a series for its full history.
Surgery Partners, Inc. (SGRY) - Revenue & ProfitRevenue & ProfitSurgery Partners, Inc. (SGRY)
Revenue (TTM)Net Income (TTM)
Powered byryufin.com